Hungarian Biotech Database

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK), one of the world's leading healthcare ecosystem platforms, signed a strategic collaboration agreement today with Merck, a leading science and technology... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Merck, a leading science and technology company, signed a strategic collaboration agreement today with one of the world's leading healthcare ecosystem platforms, Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK).... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

1 2 »

Looking for companies outside of Hungary?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

January 2020
- Basel: R&D Data Intel Leaders Forum
- Nice: AgeingFIT
February 2020
- Zürich: Swiss Nordic Bio 2020

See Events »

Add an Event »

Latest company news

Sanofi : Sanofi Completes Acquisition of Synthorx, Inc.
23 Jan 2020 (GlobenewsWire)

Sanofi: Disclosure of trading in own shares
20 Jan 2020 (GlobenewsWire)

Sanofi : Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Synthorx
20 Jan 2020 (GlobenewsWire)

News in the Life Sciences Industry

Sanofi : Sanofi Completes Acquisition of Synthorx, Inc.

Sanofi: Disclosure of trading in own shares

Sanofi : Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Synthorx

Sanofi: information concerning the total number of voting rights and shares, December 2019

Sanofi: Disclosure of trading in own shares

Sanofi: Disclosure of trading in own shares

Sanofi : Availability of the Pre-quarterly Results Communication

Sanofi: information concerning the total number of voting rights and shares, November 2019

Sanofi commences tender offer for acquisition of Synthorx, Inc.

Sanofi : Positive results presented from pivotal Phase 3 trial of sutimlimab in people with cold agglutinin disease

Sanofi and Regeneron announce intent to restructure Antibody collaboration for Kevzara® (sarilumab) and Praluent® (alirocumab)

Sanofi CEO unveils new strategy to drive innovation and growth

Sanofi : Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion

Ping An Good Doctor and Merck Form Strategic Collaboration to Advance Intelligent Healthcare in China

Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China

Sanofi: information concerning the total number of voting rights and shares, October 2019

Sanofi : FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older

Sanofi : Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes

Sanofi Q3 well on track

Sanofi announces settlement agreement related to Contingent Value Rights (CVRs) Litigation

Looking for companies outside of Hungary?

Partners

Upcoming Life Sciences Events

Latest company news